CEO Maynard Howe said that: "certification will allow us to manufacture stem cells under contract for clinical trials for Stemedica as well as for other companies and research centers in California and across the United States.”
Stemedica’s facility includes a fully manufacturing wing with entry-level gowning rooms, two ISO class 8 sterile gowning suites, ISO class 7 clean rooms for production and processing, as well as a good manufacturing process (GMP) standard materials warehouse and testing laboratory.